GBA1 and Parkinson disease: These studies have reported that carriers of severe heterozygous GBA1 mutations have approximately three to four times higher risk of developing PD compared to carriers of mild heterozygous GBA1 mutations, and they experience an earlier onset of the disease by approximately 5 years (Gan‐Or et al., 2015).